1. Home
  2. Citations

Models

Citations

PLA2G2D promotes immune escape in non-small cell lung cancer by regulating T cell immune function through PD-L1-expressing extracellular vesicles

Model Organisms：mouse Product & Service：- Research field：

Published year：2024 | References：SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS

Model Organisms：mouse Product & Service：- Research field：

Published year：2024 | References：EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model

Model Organisms：mouse Product & Service：- Research field：

Published year：2024 | References：EJNMMI Radiopharmacy and Chemistry

HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer

Model Organisms：mouse Product & Service：- Research field：

Published year：2024 | References：INTERNATIONAL JOURNAL OF ONCOLOGY

ARID5A stabilizes Indoleamine 2,3-dioxygenase expression and enhances CAR T cell exhaustion in colorectal cancer

Model Organisms：mouse Product & Service：- Research field：

Published year：2024 | References：Translational Oncology

IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer

Model Organisms：mouse Product & Service：- Research field：

Published year：2024 | References：INTERNATIONAL IMMUNOPHARMACOLOGY

FAM120A deficiency improves resistance to cisplatin in gastric cancer by promoting ferroptosis

Model Organisms：mouse Product & Service：- Research field：

Published year：2024 | References：Communications Biology

TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas

Model Organisms：mouse Product & Service：- Research field：

Published year：2024 | References：LIFE SCIENCES

The CDK4/6 inhibitor Palbociclib synergizes with ATRA to induce differentiation in AML

Model Organisms：mouse Product & Service：- Research field：

Published year：2024 | References：MOLECULAR CANCER THERAPEUTICS

INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib

Model Organisms：mouse Product & Service：- Research field：

Published year：2024 | References：BIOCHEMICAL PHARMACOLOGY

南模生物Email Back to top 点击跳转到顶部